Does POMALIDOMIDE Cause Interstitial lung disease? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Interstitial lung disease have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.1% of all adverse event reports for POMALIDOMIDE.
77
Reports of Interstitial lung disease with POMALIDOMIDE
0.1%
of all POMALIDOMIDE reports
17
Deaths
51
Hospitalizations
How Dangerous Is Interstitial lung disease From POMALIDOMIDE?
Of the 77 reports, 17 (22.1%) resulted in death, 51 (66.2%) required hospitalization, and 15 (19.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for POMALIDOMIDE.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which POMALIDOMIDE Alternatives Have Lower Interstitial lung disease Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA